Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

SHE:300957 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,457	1,810	2,091	2,514	2,035	751.95
Short-Term Investments	-	-	310	480.12	1,530	-
Trading Asset Securities	2,450	2,428	1,238	1,434	781.15	-
Cash & Short-Term Investments	3,907	4,239	3,640	4,428	4,346	751.95
Cash Growth	3.73%	16.45%	-17.80%	1.89%	477.93%	42.62%
Accounts Receivable	728.69	1,047	742.92	508.76	328.3	326.48
Other Receivables	134.56	173.14	157.87	20.47	37.81	19.33
Receivables	863.24	1,220	900.79	529.23	366.11	345.81
Inventory	625.83	611.89	904.41	670.75	463.27	253.75
Prepaid Expenses	1.39	6.95	6.98	-	2.92	5.25
Other Current Assets	103.32	55.31	70.57	87.01	46.95	34.41
Total Current Assets	5,501	6,133	5,523	5,715	5,225	1,391
Property, Plant & Equipment	892.16	936.82	808.14	665.36	431.96	109.29
Long-Term Investments	438.02	375.95	298.46	82.78	-	-
Goodwill	323.05	323.05	413.74	-	-	-
Other Intangible Assets	443.94	258.52	193.11	77.94	64.59	55.16
Long-Term Deferred Tax Assets	105.64	129.34	93.13	52.12	15.58	13.35
Long-Term Deferred Charges	114.23	113.59	93.32	66.73	41.02	20.36
Other Long-Term Assets	160.76	33.38	84.45	59.63	34.31	12.53
Total Assets	7,979	8,304	7,507	6,720	5,812	1,602
Accounts Payable	377.57	447.18	401.93	372.37	361.61	134.84
Accrued Expenses	271.36	457.76	469.93	312.06	285.73	150.21
Short-Term Debt	437.1	314.56	103.82	-	-	-
Current Portion of Leases	74.51	63.33	42.1	62.42	48.91	-
Current Income Taxes Payable	21.9	70	105.22	109.69	97.54	65.78
Current Unearned Revenue	67.8	98.97	50.05	58.12	71.19	36.5
Other Current Liabilities	60.78	66.13	118.16	77.21	34.78	3.86
Total Current Liabilities	1,311	1,518	1,291	991.87	899.75	391.19
Long-Term Debt	257.74	321.66	4.7	-	-	-
Long-Term Leases	92.43	118.23	63.28	50.95	76.29	-
Long-Term Unearned Revenue	98.17	112.37	82.86	55.57	6.3	7.41
Long-Term Deferred Tax Liabilities	22.22	33.3	40.45	8.36	1.69	-
Other Long-Term Liabilities	7.41	12.25	8.6	10.5	50	1.45
Total Liabilities	1,789	2,116	1,491	1,117	1,034	400.05
Common Stock	423.6	423.6	423.6	423.6	423.6	360
Additional Paid-In Capital	2,825	2,817	2,846	2,846	2,846	25.71
Retained Earnings	2,946	2,952	2,701	2,283	1,486	813.3
Treasury Stock	-144.96	-144.96	-109.84	-	-	-
Comprehensive Income & Other	1.96	2.05	0.05	-0	0	-
Total Common Equity	6,051	6,050	5,861	5,553	4,755	1,199
Minority Interest	138.94	137.92	154.82	49.48	23.26	2.81
Shareholders' Equity	6,190	6,188	6,016	5,602	4,778	1,202
Total Liabilities & Equity	7,979	8,304	7,507	6,720	5,812	1,602
Total Debt	861.79	817.77	213.9	113.36	125.2	-
Net Cash (Debt)	3,046	3,421	3,426	4,315	4,221	751.95
Net Cash Growth	2.11%	-0.14%	-20.60%	2.23%	461.28%	46.79%
Net Cash Per Share	7.23	8.16	8.10	10.18	10.37	2.09
Filing Date Shares Outstanding	419.95	421.29	420.61	423.6	423.6	423.6
Total Common Shares Outstanding	419.95	421.29	420.61	423.6	423.6	360
Working Capital	4,190	4,615	4,231	4,723	4,325	999.98
Book Value Per Share	14.41	14.36	13.93	13.11	11.23	3.33
Tangible Book Value	5,284	5,468	5,254	5,475	4,691	1,144
Tangible Book Value Per Share	12.58	12.98	12.49	12.92	11.07	3.18
Buildings	265.79	251.48	261.2	50.35	33.8	33.8
Machinery	679.5	649.81	527.8	228.01	124.7	68.73
Construction In Progress	16.28	50.76	40.22	349.47	197.29	40.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.